ArticleBritish journal of haematology2014

Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).

Anita K Gandhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.